Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
INJECTION
**【DOSAGE AND ADMINISTRATION】** - **Peripheral neuropathies** The usual dosage for adults is 1 ampoule (500 mcg of mecobalamin) per day, administered intramuscularly or intravenously 3 times a week. The dosage may be adjusted depending on the patient's age and symptoms. - **Megaloblastic anemia** The usual dosage for adults is 1 ampoule (500 mcg of mecobalamin) per day, administered intramuscularly or intravenously 3 times a week. After about 2 months of medication, the dose should be reduced to a single administration of 1 ampoule at 1 to 3 months intervals for maintenance therapy.
INTRAVENOUS
Medical Information
**【INDICATIONS】** Peripheral neuropathies Megaloblastic anemia caused by vitamin B12 deficiency < **Precautions** > METHYCOBAL should not be used aimlessly for more than one month unless it is effective.
**2\. Contraindication** Hypersensitivity to any form of vitamin B12 or D-mannitol.
B03BA05
mecobalamin
Manufacturer Information
EISAI (SINGAPORE) PTE. LTD.
Nipro Pharma Corporation Ise Plant
Active Ingredients
Documents
Package Inserts
Methycobal Injection PI.pdf
Approved: September 20, 2017